OBESITY AND ITS RELATIONSHIP WITH CANCER: PART III

Breast, Colorectal, Esophageal, Gastric, Gall Bladder, Liver Cancers

Authors

  • Shashi K. Agarwal Center for Contemporary and Complementary Cardiology, USA

DOI:

https://doi.org/10.46545/aijcs.v3i1.218

Keywords:

OBESITY, CANCER

Abstract

Obesity and cancer has been discussed in the first two parts. This part (Part III) deals with six cancers, namely those involving the breast, colorectal tissues, esophagus, stomach. gall bladder, and liver. Their relationship with obesity is discussed. Part IV will look at endometrial, ovarian, pancreatic, prostate, renal, thyroid and lung carcinomas. Meningioma and multiple myeloma are also discussed.

Downloads

Download data is not yet available.

Author Biography

  • Shashi K. Agarwal, Center for Contemporary and Complementary Cardiology, USA

    Center for Contemporary and Complementary Cardiology

    2227 US Highway 1, Suite 309, North Brunswick, NJ 08902, USA

References

Abnet CC, Freedman ND, Hollenbeck AR, et al. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer. 2008;44:465–71.

Aleksandrova K, Schlesinger S, Fedirko V, et al. Metabolic Mediators of the Association Between Adult Weight Gain and Colorectal Cancer: Data From the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Am J Epidemiol. 2017;185(9):751-764.

Alemán JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146:357–73.

American Cancer Society Survival Rates for Esophageal Cancer 2020 - accessed on 10 June 2020. Available online: https://www.cancer.org/cancer/esophagus-cancer/detection-diagnosis-staging/survival-rates.html#references

Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–94.

Baecker A, Liu X, La Vecchia C, Zhang ZF. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018 May;27((3)):205–12.

Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150(1):17-22. doi:10.1001/jamasurg.2014.1756.

Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62:933–947. doi: 10.1136/gutjnl-2013-304701.

Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, et al. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery. 2019 Oct;166((4)):547–55.

Bjørge T, Engeland A, Tverdal A, Smith GD. Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol. 2008 Jul 1;168(1):30-7. doi: 10.1093/aje/kwn096.

Bray F., Ferlay J., Soerjomataram I. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492.

Bruno D.S., Berger N.A. Impact of bariatric surgery on cancer risk reduction. Ann. Transl. Med. 2020;8:S13. doi: 10.21037/atm.2019.09.26.

Burasakarn P, Thienhiran A, Hongjinda S, Fuengfoo P. The optimal extent of surgery in T2 gallbladder cancer and the need for hepatectomy: A meta-analysis. Asian J Surg. 2021 May 26:S1015-9584(21)00262-1. doi: 10.1016/j.asjsur.2021.05.005.

Campbell PT, Jacobs ET, Ulrich CM, et al. Colon Cancer Family R. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010;102(6):391–400.

Castagneto-Gissey L., Casella-Mariolo J., Casella G., Mingrone G. Obesity Surgery and Cancer: What Are the Unanswered Questions? Front. Endocrinol. 2020;11:213. doi: 10.3389/fendo.2020.00213.

Chan D.S.M., Vieira A.R., Aune D., et al. Body mass index and survival in women with breast cancer—Systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 2014;25:1901–1914. doi: 10.1093/annonc/mdu042.

Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48:2137–2145.

Chow W-H, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–5.

Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–62.

de Jonge PJ, Steyerberg EW, Kuipers EJ, et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2006;101:1421–9.

Derogar M, Hull MA, Kant P, et al. Increased risk of colorectal cancer after obesity surgery. Ann Surg 2013;258:983-8. 10.1097/SLA.0b013e318288463a.

Donato GB, Fuchs SC, Oppermann K, et al. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006;13:280–285.

EASL. European Association for the Study of the Liver. European Association for the Study of Diabetes (EASD). European Association for the Study of Obesity (EASO) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64((6)):1388–402.

Eliassen AH , Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.

Emerenziani S, Rescio MP, Guarino MP, Cicala M. Gastro-esophageal reflux disease and obesity, where is the link? World J Gastroenterol. 2013 Oct 21;19(39):6536-9. doi: 10.3748/wjg.v19.i39.6536.

Ewertz M., Jensen M.B., Gunnarsdóttir K.Á., et al. Effect of obesity on prognosis after early-stage breast cancer. J. Clin. Oncol. 2011;29:25–31. doi: 10.1200/JCO.2010.29.7614.

Fang X., Wei J., He X., et al. Quantitative association between body mass index and the risk of cancer: A global Meta-analysis of prospective cohort studies. Int. J. Cancer. 2018;143:1595–1603. doi: 10.1002/ijc.31553.

Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

Fitzmaurice C., Abate D., Abbasi N., et al. Global Burden of Disease Cancer Collaboration et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5:1749–1768. doi: 10.1001/jamaoncol.2019.2996.

Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. J Am Med Ass. 2010;303:235–241.

Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3(3):153-173. doi:10.3978/j.issn.2078-6891.2012.030.

Florio AA, Campbell PT, Zhang X, et al. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. Int J Cancer. 2020 Aug 1;147(3):675-685. doi: 10.1002/ijc.32760.

García-Estévez Laura, Cortés Javier, Pérez Silvia, Calvo Isabel, Gallegos Isabel, Moreno-Bueno Gema. Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status. Front. Oncol., 13 August 2021. https://doi.org/10.3389/fonc.2021.705911.

Gg Solaymani-Dodaran M, Logan RF, West J, et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut. 2004;53:1070–4.

Giri, S., Pathak, R., Aryal, M.R. et al. Incidence trend of esophageal squamous cell carcinoma: an analysis of Surveillance Epidemiology, and End Results (SEER) database. Cancer Causes Control 26, 159–161 (2015). https://doi.org/10.1007/s10552-014-0485-0.

Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.

Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251-261. doi:10.3978/j.issn.2078-6891.2012.021

Hull MA, Markar SR, Morris EJA. Cancer risk after bariatric surgery - is colorectal cancer a special case? Nat Rev Gastroenterol Hepatol 2018;15:653-4. 10.1038/s41575-018-0070-1.

Ishihara BP, Farah D, Fonseca MCM, Nazario A. The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis. Surg Obes Relat Dis. 2020 Oct;16(10):1596-1602. doi: 10.1016/j.soard.2020.06.008.

Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018 Jan;68((1)):31–54.

Islam, K. M. A., Khan, M. A. U., Azhar, S., Ahmed, M. R., Khurram, S., Masood, H., & Farooq, L. (2020). Comparison Of In Vitro Activity of Colistin with Ceftolozane/Tazobactam against Multi Drug Resistant Pseudomonas Aeruginosa “A Last Line Treatment against Mdr”. American International Journal of Multidisciplinary Scientific Research, 6(3), 1-7.

Kai, M., Chijiiwa, K., Ohuchida, J. et al. A Curative Resection Improves the Postoperative Survival Rate Even in Patients with Advanced Gallbladder Carcinoma. J Gastrointest Surg 11, 1025–1032 (2007). https://doi.org/10.1007/s11605-007-0181-4.

Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–13. 10.1158/1055-9965.EPI-13-1057.

Keum, N., Giovannucci, E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 16, 713–732 (2019). https://doi.org/10.1038/s41575-019-0189-8.

Kozakowski J, Gietka-Czernel M, Leszczyńska D, Majos A. Obesity in menopause - our negligence or an unfortunate inevitability?. Prz Menopauzalny. 2017;16(2):61-65. doi:10.5114/pm.2017.68594.

Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:872–8.

Kyrgiou M., Kalliala I., Markozannes G., Gunter M.J., Paraskevaidis E., Gabra H., Martin-Hirsch P., Tsilidis K.K. Adiposity and cancer at major anatomical sites: Umbrella review of the literature. BMJ. 2017;356:477. doi: 10.1136/bmj.j477.

Lagergren J, Bergstro¨m R, Nyre´n O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883–90.

Lauby‐Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. International agency for research on cancer handbook working Group . The IARC perspective on colorectal cancer screening. N Engl J Med 2018; 378: 1734–40.

Lee YJ, Myung SK, Cho B, Park BJ, Park JH, Ju W, Park MS, Choi JH. Adiposity and the risk of colorectal adenomatous polyps: A meta-analysis. Cancer Causes Control. 2011;22:1021–1035. doi: 10.1007/s10552-011-9777-9.

Levi Z, Kark JD, Katz LH, et al. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study. Cancer. 2017 Oct;123((20)):4022–30.

Liu PH, Wu K, Ng K, et al. Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women. JAMA Oncol. 2019 Jan 1;5(1):37-44. doi: 10.1001/jamaoncol.2018.4280.

Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med 2017;23:859-68. 54.

Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.

Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.

Loomba R, Yang HI, Su J, Brenner D, Barrett-Connor E, Iloeje U, et al. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol. 2013 Feb;177((4)):333–42.

Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: A systematic review of prospective studies. PLoS One. 2013;8:e53916. doi: 10.1371/journal.pone.0053916.

Martinez-Useros J, Garcia-Foncillas J. Obesity and colorectal cancer: molecular features of adipose tissue. Journal of translational medicine. 2016;14(1):21.

Matsuo K, Mizoue T, Tanaka K, et al. Association between body mass index and the colorectal cancer risk in Japan: Pooled analysis of population-based cohort studies in Japan. Ann Oncol. 2012;23:479–490. doi: 10.1093/annonc/mdr143.

Meyer J, Rohrmann S, Bopp M, Faeh D, Swiss National Cohort Study Group Swiss National cohort study group. Impact of smoking and excess body weight on overall and site-specific cancer mortality risk. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24((10)):1516–22.

Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. Journal of Clinical Oncology 2004; 22(4):648-657.

Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2533-47. doi: 10.1158/1055-9965.EPI-07-0708.

Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36:114-136. doi:10.1093/epirev/mxt010.

Murphy N, Jenab M, Gunter MJ. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat Rev Gastroenterol Hepatol. 2018;15(11):659-670. 148.

Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol. 2015;1:611-621. doi:10.1001/jamaoncol.2015.1546.

Nimptsch K, Steffen A, Pischon T. Obesity and Oesophageal Cancer. Recent Results Cancer Res. 2016;208:67-80. doi: 10.1007/978-3-319-42542-9_4.

O’Sullivan J., Lysaght J., Donohoe C.L., Reynolds J.V. Obesity and gastrointestinal cancer: The interrelationship of adipose and tumour microenvironments. Nat. Rev. Gastroenterol. Hepatol. 2018;15:699–714. doi: 10.1038/s41575-018-0069-7.

Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of Obesity Among Adults and Youth: United States, 2011‐2014. NCHS Data Brief, no. 201. Hyattsville, MD: National Center for Health Statistics; 2015.

Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg 2010;252:972-6.

Parra-Soto S, Cowley ES, Rezende LFM, et al. Associations of six adiposity-related markers with incidence and mortality from 24 cancers-findings from the UK Biobank prospective cohort study. BMC Med. 2021;19(1):7. Published 2021 Jan 11. doi:10.1186/s12916-020-01848-8.

Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. Journal of Clinical Oncology 2012; 30(30):3726-3733.

Pennathur A., Gibson M.K., Jobe B.A., Luketich J.D. Oesophageal carcinoma. Lancet. 2013;381:400–412. doi: 10.1016/S0140-6736(12)60643-6.

Petrick JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, Wactawski-Wende J, Van Dyke AL, et al. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. Am J Gastroenterol. 2018 Oct;113((10)):1494–505.

Rastaghi S, Jafari-Koshki T, Mahaki B, Bashiri Y, Mehrabani K, Soleimani A. Trends and risk factors of gastric cancer in Iran (2005–2010) Int J Prev Med. 2019;10:79.

Recalde M, Davila-Batista V, Díaz Y, Leitzmann M, Romieu I, Freisling H, Duarte-Salles T. Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med. 2021 Jan 14;19(1):10. doi: 10.1186/s12916-020-01877-3.

Recio-Boiles A, Babiker HM. Esophageal Cancer. 2021 Jul 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.

Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer Incidence and Mortality in Relation to Body Mass Index in the Million Women Study: Cohort Study. BMJ (2007) 335(7630):1134. doi: 10.1136/bmj.39367.495995.

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569-578. doi:10.1016/S0140-6736(08)60269-X.

Roeb E, Steffen HM, Bantel H, Baumann U, Canbay A, Demir M, et al. [S2k Guideline non-alcoholic fatty liver disease] Z Gastroenterol. 2015 Jul;53((7)):668–723.

Rui R, Lou J, Zou L, Zhong R, Wang J, Xia D, et al. Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies. PLoS One. 2012;7:e44522.

Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev 2008;17:1401-10.

Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann Surg 2019;269:95-101.

Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1695-8. doi: 10.1158/1055-9965.EPI-09-0186.

Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2020. CA Cancer J Clin. 2020;70(1):7-34.

Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219-34.

Sohn W, Lee HW, Lee S, et al. Obesity and the risk of primary liver cancer: A systematic review and meta-analysis. Clin Mol Hepatol. 2021;27(1):157-174. doi:10.3350/cmh.2020.0176.

Song M, Hu FB, Spiegelman D, Chan AT, Wu K, Ogino S, Fuchs CS, Willett WC, Giovannucci EL. Long-term status and change of body fat distribution, and risk of colorectal cancer: A prospective cohort study. Int J Epidemiol. 2016;45:871–883. doi: 10.1093/ije/dyv177.

Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013 Aug 14;310(6):627-36. doi: 10.1001/jama.2013.226450.

Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surgical Endoscopy 2013; 27(12):4449-4456.

van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-527. doi:10.1093/aje/152.6.514.

Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. 2019 Oct;68((10)):1820–6; https://nccrt.org/crc-death-rates-rising-under55/.

Wang Y, Wang B, Shen F, Fan J, Cao H. Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies. Oncologist. 2012;17:1461–1468.

Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, et al. International incidence and mortality trends of liver cancer: a global profile. Sci Rep. 2017;7:45846.

www.wcrf.org.

www.aicr.org.

www.nichd.nih.gov.

www.cancer.org

Xue K, Li FF, Chen YW, Zhou YH, He J. Body mass index and the risk of cancer in women compared with men: a meta-analysis of prospective cohort studies. European J Cancer Prev. 2017;26(1):94-105.

Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. Overweight, obesity and gastric cancer risk: Results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45:2867–73.

Yu MW, Lin CL, Liu CJ, Yang SH, Tseng YL, Wu CF. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: A large cohort study. Gastroenterology. 2017 Oct;153((4)):1006–1017.e5.

Zali H, Rezaei-Tavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4(4):175-185.

Zheng J, Zhao M, Li J, Lou G, Yuan Y, Bu S, et al. Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumor Biol. 2017;39:1010428317695020.

Downloads

Published

2021-11-06

Issue

Section

Original Articles/Review Articles/Case Reports/Short Communications

How to Cite

OBESITY AND ITS RELATIONSHIP WITH CANCER: PART III: Breast, Colorectal, Esophageal, Gastric, Gall Bladder, Liver Cancers. (2021). American International Journal of Cancer Studies , 3(1), 25-36. https://doi.org/10.46545/aijcs.v3i1.218

Similar Articles

1-10 of 11

You may also start an advanced similarity search for this article.